For example, MTOR is a well-characterized oncogene in several cancers (including cancers of the lung) and its activation promotes cell proliferation, migration, and invasion, thus necessitating pharmacological MTOR inhibition to prevent this uncontrolled growth (25, 66, 67, 68). This evidence concerns the gene MTOR and lung carcinoma.